Analysis

Dr. Reddy's Laboratories Ltd. (DRREDDY) Stock Analysis

Dr. Reddy's Laboratories Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to DRREDDY.

websiteDRREDDY/analysis/DRREDDY

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to DRREDDY.

Stock profile

Ticker

DRREDDY

Asset type

Stock

Market cap

$11.21B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

INR

Ticker listings

Dr. Reddy's Laboratories Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • DRREDDY primary listing
  • RDY
  • RDDA
  • R1DY34
  • 659157

Latest Dr. Reddy's Laboratories Ltd. news

Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States

HYDERABAD, India & PRINCETON, N.J., June 13, 2026--Dr. Reddy’s Laboratories Ltd. announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif...

Dr Reddy Laboratories : Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F)

Dr Reddy Laboratories : Annual Report for Fiscal Year Ending March 31, 2026 (Form

Press Release May 28 2026

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Dr. Reddy's Laboratories to Ring the Closing Bell® at the New Yo...

Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada

HYDERABAD, India & MISSISSAUGA, Ontario, May 16, 2026--Dr. Reddy’s Laboratories Ltd. a global pharmaceutical company, today announced the launch of its generic Semaglutide Injec...

Press Release May 16 2026

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Dr. Reddy's Laboratories Launches its Generic Semaglutide Inject...

Research sections

Valuation

Review valuation context for Dr. Reddy's Laboratories Ltd..

Future growth

Review future growth context for Dr. Reddy's Laboratories Ltd..

Past performance

Review past performance context for Dr. Reddy's Laboratories Ltd..

Financial health

Review financial health context for Dr. Reddy's Laboratories Ltd..

Dividend

Review dividend context for Dr. Reddy's Laboratories Ltd..

Management

Review management context for Dr. Reddy's Laboratories Ltd..

Ownership

Review ownership context for Dr. Reddy's Laboratories Ltd..

Other information

Review other information context for Dr. Reddy's Laboratories Ltd..

Community

Review community context for Dr. Reddy's Laboratories Ltd..